The RetraLabs
Foundation.
"At RetraLabs, we source our peptides directly from trusted manufacturers from our partner china who offer genuine quality at transparent, fair pricing. Our goal is simple: to provide legit, research-grade peptides at reasonable prices without scams or shortcuts."
We are new to the Indian market, and we genuinely appreciate your support as we build something reliable and long-term here.
Before starting RetraLabs, we personally faced difficulties finding authentic peptide sources in India. Through extensive research, we realized that there is currently no verified, genuine source of Retatrutide or other UGL peptides available domestically. That gap is exactly why RetraLabs exists.
We operate with complete transparency and integrity. All products are handled carefully, and we take responsibility for sourcing, customs clearance, and quality control. Our focus is on purity, consistency, and honest communication.
The Trust Covenant
Trust is earned. If you feel a product is not performing as expected, or if you have a valid lab report showing purity below acceptable standards, we are open to discussion and will offer a refund or appropriate compensation.
Important: Retatrutide is currently not FDA-approved and is intended for laboratory research only.
Engineered for
Scientific Elite.
RetraLabs delivers pharmaceutical-grade peptides synthesized for the most rigorous research standards. Transparent, pure, and unapologetically premium.
The Collection.
Engineered for absolute purity. Our compounds represent the pinnacle of current peptide synthesis technology.
Retatrutide
Triple Agonist Construct
The most advanced metabolic research compound currently synthesized. Engineered for unprecedented receptor affinity.
Analyze DosagesTirzepatide
Dual Agonist Protocol
Currently undergoing final molecular stability verification. Advanced weight management pathways.
Semaglutide
GLP-1 Receptor Agonist
Clinical Analysis:
Retatrutide.
Retatrutide (LY3437943) represents a breakthrough in metabolic research as a **Triple Agonist Construct**, targeting GIP, GLP-1, and Glucagon receptors simultaneously.
Phase 2 trials @ 48 weeks (highest dose)
GIP, GLP-1, and GCGR multi-pathway activation
Retatrutide research suggests enhanced energy expenditure through glucagon receptor activation, differentiating it from dual-agonist protocols.
Crowdsourced Research
For real-world laboratory discussions, protocol optimizations, and peer-reviewed dosing analysis, we strongly recommend visiting the Retatrutide research community on Reddit.
Research Catalogues.
Select verified concentrations for your specific laboratory research requirements.
Retatrutide Protocol
Retatrutide
5mg * 10 VIALS PER KIT
Retatrutide
10MG * 10 VIALS PER KIT
Synthesis Pipeline
GHK-Cu
In Stability Testing
HGH 191AA
Quality Control
IGF-1 LR3
Synthesis Step 04
5-Amino-1MQ
Awaiting Raw Batch
Strict Research Protocol.
RetraLabs maintains the highest ethical standards in biotech distribution. All compounds listed are strictly for In-Vitro Laboratory Research.